Implications of increased tissue transglutaminase (TG2) expression in drug-resistant breast cancer (MCF-7) cells

Oncogene

Volumn 25, Issue 21, 2006, Pages 3049-3058

  Herman, J F ^a   Mangala, L S ^a   Mehta, K ^a,b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

Apoptosis; Chemoresistance; Integrins; Tissue transglutaminase

Indexed keywords

BETA1 INTEGRIN; BETA5 INTEGRIN; CALCIUM; DOXORUBICIN; FIBRONECTIN; FOCAL ADHESION KINASE; INTEGRIN; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; SMALL INTERFERING RNA;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL ADHESION; CELL FUNCTION; CELL GROWTH; CELL STRAIN MCF 7; CELL SURFACE; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; INCUBATION TIME; PHENOTYPE; PRIORITY JOURNAL; PROTEIN CROSS LINKING; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN PROTEIN INTERACTION;

ADENOCARCINOMA; ANTIGENS, CD29; ANTINEOPLASTIC AGENTS; APOPTOSIS; BREAST NEOPLASMS; CELL ADHESION; CELL LINE, TUMOR; CULTURE MEDIA, SERUM-FREE; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; ENZYME INDUCTION; FEMALE; FIBRONECTINS; FOCAL ADHESION KINASE 1; HUMANS; INTEGRIN ALPHA4; INTEGRIN ALPHA5; INTEGRIN BETA CHAINS; NEOPLASM PROTEINS; P-GLYCOPROTEIN; RNA, SMALL INTERFERING; TRANSGLUTAMINASES;

EID: 33646858986     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1209324     Document Type: Article

References (44)

1. Akimov S, Belkin A. (2001). J Cell Sci 114: 2989-3000.
2. Akimov SA, Krylov D, Fleishman L, Belkin AM. (2000). J Cell Biol 148: 825-838.
3. Antonyak M, Singh U, Lee D, Boehm J, Combs C, Zgola M et al. (2001). J Biol Chem 279: 8715-8722.
4. Antonyak MA, Miller AM, Jansen JM, Boehm JE, Balkman CE, Wakshlag JJ et al. (2004). J Biol Chem 279: 41461-41467.
5. Aoudjit F, Vuori K. (2001). Oncogene 20: 4995-5004.
6. Autuori F, Farrace M, Oliverio S, Piredda L, Piacentini M. (1998). Adv Biochem Eng Biotechnol 62: 129-136.
7. Boehm JE, Singh U, Combs C, Antonyak MA, Cerione RA. (2002). J Biol Chem 23: 20127-20130.
8. Cary LA, Chang JF, Guan JL. (1996). J Cell Sci 109: 1787-1794.
9. Chen J, Agarwal N, Mehta K. (2002). Br Cancer Res Treat 71: 237-247.
10. Chen J, Mehta K. (1999). Int J Biochem Cell Biol 31: 817-836.
11. Chen J, Kanopleva M, Multani A, Pathak S, Mehta K. (2004). J Cell Physiol 200: 223-234.
12. Cordes N, Blaese M, Plasswilm L, Rodemann H, Van Beuningen D. (2003). Int J Radiat Biol 79: 709-720.
13. Damiano JS, Cress AE, Hazlehurst LA, Shtil AA, Dalton WS. (1999). Blood 93: 1658-1667.
14. Damiano JS, Hazlehurst LA, Dalton WS. (2001). Leukemia 15: 1232-1239.
15. Danen EH, Yamada KM. (2001). J Cell Physiol 189: 1-13.
16. Davies PJ, Piacentini M. (1994). Mol Cell Biol 14: 6584-6596.
17. de la Fuente MT, Casanova B, Moyano JV, Garcia-Gila M, Sanz L, Garcia-Marco J et al. (2002). J Leukoc Biol 71: 495-502.
18. De Laurenzi V, Melino G. (2001). Mol Cell Biol 21: 148-155.
19. Devarajan E, Multani A, Pathak S, Sahin A, Mehta K. (2002). Int J Oncol 20: 913-920.
20. Fesus L, Davies P, Piacentini M. (1991). Eur J Cell Biol 56: 170-177.
21. Guan JL. (1997). Int J Biochem Cell Biol 29: 1085-1096.
22. Hang J, Zemskov EA, Lorand L, Belkin AM. (2005). J Biol Chem 280: 23675-23683.
23. Ilic D, Furuta Y, Kanazawa S, Takeda N, Sobue K, Nakatsuji N et al. (1995). Nature 377: 539-544.
24. Jeong JM, Murthy SNP, Radek JT, Lorand L. (1995). J Biol Chem 270: 5654-5658.
25. Korah R, Boots M, Wieder R. (2004). Cancer Res 64: 4514-4522.
26. Longtin R. (2004). J Natl Cancer Inst 96: 6-8.
27. Lorand L, Graham R. (2003). Nat Mol Cell Biol 4: 140-156.
28. Mangala LS, Mehta K. (2005). Tissue transglutaminase in cancer. In: Mehta K and Eckert R (eds), Progress in Experimental Tumor Research. AG Karger Press: Basel, pp 125-138.
29. Mauro L, Sisci D, Bartucci M, Salerno M, Kim J, Tam T. (1999). Exp Cell Res 252: 439-448.
30. Mehta K, Devarajan E, Chen J, Multani A, Pathak P. (2002). J Natl Cancer Inst 94: 1652-1654.
31. Mehta K, Fok J, Miller FR, Koul K, Sahin AA. (2004). Clin Cancer Res 10: 8068-8076.
32. Mehta K. (1994). Int J Cancer 58: 400-406.
33. Milakovic T, Tuchoiski J, McCoy E, Johnson G. (2004). J Biol Chem 279: 8715-8722.
34. Nanda M, Ismaa SE, Owen WA, Husain A, Mackay F, Graham RM. (2001). J Biol Chem 276: 20673-20678.
35. Nista A, Leonetti C, Bernardini G, Mattioni M, Santoni A. (1997). Int J Cancer 72: 133-141.
36. Oliverio S, Amendola A, Di Sano F, Farrace MG, Fesus L, Nemes Z et al. (1997). Mol Cell Biol 17: 6040-6048.
37. Parise L, Lee J, Juliano R. (2000). Semin Cancer Biol 10: 407-414.
38. Price LS, Leng J, Schwartz MA, Bokoch GM. (1998). Mol Cell Biol 9: 1863-1871.
39. Roovers K, Davey G, Zhu X, Bottazzi ME, Assoian RK. (1999). Mol Biol Cell 10: 3197-3204.
40. Schlaepfer DD, Hauck CR, Sieg DJ. (1999). Prog Biophys Mol Biol 71: 435-478.
41. Schlaepfer DD, Mitra SK, Ilic D. (2004). Biochim Biophys Acta 1692: 77-102.
42. Sonoda Y, Matsumoto Y, Funakoshi M, Yamamoto D, Hanks SK, Kasahara T. (2000). J Biol Chem 275: 16309-16315.
43. Xu LH, Yang X, Craven RJ, Cance WJ. (1998). Cell Growth Differ 9: 999-1005.
44. Zhang Z, Vuori K, Read JC, Ruoslahti E. (1995). Proc Natl Acad Sci USA 92: 6161-6165.